Pheton Holdings Ltd (PTHL)
- Previous Close
17.29 - Open
17.30 - Bid 17.00 x 200
- Ask 16.95 x 100
- Day's Range
16.90 - 17.94 - 52 Week Range
1.32 - 19.05 - Volume
364,063 - Avg. Volume
392,653 - Market Cap (intraday)
389.045M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.05 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
www.ftzy.com.cnRecent News: PTHL
View MorePerformance Overview: PTHL
Trailing total returns as of 6/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PTHL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PTHL
View MoreValuation Measures
Market Cap
246.38M
Enterprise Value
240.47M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
490.75
Price/Book (mrq)
39.84
Enterprise Value/Revenue
536.53
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-147.39%
Return on Assets (ttm)
-11.55%
Return on Equity (ttm)
-20.35%
Revenue (ttm)
448.2k
Net Income Avi to Common (ttm)
-660.59k
Diluted EPS (ttm)
-0.05
Balance Sheet and Cash Flow
Total Cash (mrq)
6.16M
Total Debt/Equity (mrq)
4.01%
Levered Free Cash Flow (ttm)
-1.48M